Recent Updates
Recently added Catalysts
CAPR Negative Sentiment Score: 30/100

Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Key Takeaway: Johnson Fistel, PLLP has announced an investigation into potential legal claims on behalf of Capricor Therapeutics, Inc. shareholders due to alleged misconduct by the company's executives. This investigation is focused on actions that may have negatively impacted the company and its investors. Shareholders who have held shares since before October 9, 2024, are encouraged to reach out for more information regarding their rights. The firm is known for representing shareholders in legal actions and has had significant recoveries in the past.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investigation into alleged misconduct by Capricor's officers and directors.
  • Concerns about potential harm to the company and its investors.
  • Legal claims may indicate governance issues within the company.

Full Press Release Details

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Capricor Therapeutics, Inc. (NASDAQ: CAPR) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.
Investors who have continuously held Capricor shares since before October 9, 2024, may have legal rights and are encouraged to contact the firm to learn more:
You may be able to pursue changes to the company’s corporate governance practices, seek the recovery of funds for the company, and request a court-approved incentive award, all at no cost to you. Please contact Johnson Fistel at (619) 814-4471 to learn more.
About Johnson Fistel, PLLP:
Johnson Fistel is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in derivative and securities class actions and has recovered over $90 million for clients while earning repeated recognition among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication.
Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations, (619) 814-4471

Tags

Frequently Asked Questions

What is Johnson Fistel investigating?

They are probing potential legal claims for Capricor Therapeutics shareholders over alleged misconduct.

Who can participate in the investigation?

Shareholders who held Capricor shares since before October 9, 2024, may have legal rights.

What can shareholders achieve through Johnson Fistel?

They can pursue corporate governance changes, fund recovery, and incentive awards at no cost.

Where is Johnson Fistel located?

The firm has offices in California, New York, Georgia, and Colorado.

How much has Johnson Fistel recovered for clients?

They have recovered over $90 million for clients in various actions.

Last updated: Nov 4, 2025